Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's Intraday Session

 

Gainers

  • Ventyx Biosciences (NASDAQ:VTYX) shares moved upwards by 61.0% to $37.18 during Monday's regular session. The current volume of 12.9 million shares is 4790.0% of Ventyx Biosciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $1.8 billion.
  • Clovis Oncology (NASDAQ:CLVS) stock moved upwards by 33.92% to $1.54. Clovis Oncology's stock is trading at a volume of 21.1 million shares as of 13:30 EST. This is 175.8% of its average full-day volume over the last 100 days. The company's market cap stands at $222.5 million.
  • Regulus Therapeutics (NASDAQ:RGLS) shares moved upwards by 27.97% to $2.15. As of 13:30 EST, Regulus Therapeutics's stock is trading at a volume of 40.3 million, which is 13295.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $31.4 million.
  • IDEAYA Biosciences (NASDAQ:IDYA) stock increased by 27.23% to $11.77. As of 13:30 EST, IDEAYA Biosciences's stock is trading at a volume of 1.5 million, which is 474.0% of its average full-day volume over the last 100 days. The company's market cap stands at $462.5 million.
  • Annovis Bio (NYSE:ANVS) shares rose 24.83% to $19.1. As of 13:30 EST, Annovis Bio's stock is trading at a volume of 355.2K, which is 458.5% of its average full-day volume over the last 100 days. The company's market cap stands at $155.9 million.
  • ImmunityBio (NASDAQ:IBRX) shares increased by 18.1% to $5.48. ImmunityBio's stock is trading at a volume of 2.5 million shares as of 13:30 EST. This is 175.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.1 billion.

Losers

  • Akari Therapeutics (NASDAQ:AKTX) stock decreased by 26.0% to $0.77 during Monday's regular session. Trading volume for this security as of 13:30 EST is 644.7K, which is 981.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.6 million.
  • Entrada Therapeutics (NASDAQ:TRDA) shares decreased by 17.97% to $12.24. As of 13:30 EST, this security is trading at a volume of 59.0K shares, making up 65.2% of its average full-day volume over the last 100 days. The company's market cap stands at $383.9 million.
  • Leap Therapeutics (NASDAQ:LPTX) shares declined by 17.76% to $1.39. Trading volume for Leap Therapeutics's stock is 1.7 million as of 13:30 EST. This is 285.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $137.6 million.
  • DICE Therapeutics (NASDAQ:DICE) shares decreased by 13.51% to $19.59. As of 13:30 EST, this security is trading at a volume of 1.6 million shares, making up 446.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $748.5 million.
  • AnPac Bio-Medical Science (NASDAQ:ANPC) stock declined by 12.96% to $0.17. Trading volume for AnPac Bio-Medical Science's stock is 649.0K as of 13:30 EST. This is 24.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.8 million.
  • AN2 Therapeutics (NASDAQ:ANTX) stock decreased by 12.92% to $8.23. The market value of their outstanding shares is at $159.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.